Latest Breaking News On - பொன் பள்ளி - Page 1 : comparemela.com

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Medexus Pharmaceuticals and medac GmbH enter into a License Agreement for First-in-Class . Medexus Pharmaceuticals IncFebruary 2, 2021 GMT Orphan Designated Drug with August 2021 PDUFA date Management to host conference call at 10:00 AM Eastern Time on February 3, 2021 and Key Opinion Leader webinar to be held at 2:00 PM Eastern Time on February 5, 2021 TORONTO and CHICAGO and MONTREAL and WEDEL, Germany, Feb. 02, 2021 (GLOBE NEWSWIRE) Medexus Pharmaceuticals Inc. (“Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) is pleased to announce that it and its wholly-owned United States-based subsidiary, Medexus Pharma, Inc. (“Medexus Pharma” and together with Medexus, the “Company”) entered into a Commercialization and Supply Agreement with medac Gesellschaft für klinische Spezialpräparate m.b.H. (“medac”), pursuant to which medac has granted Medexus Pharma an excl

United statesNordrhein westfalenDwet alMiklos koharyNatalia zimonyi koharyTina byersMary horowitzRoland boivinMedexus pharmaH joachim deegMarrow transplant researchRoberta uihlein professor of hematologic researchDeputy cancer centerInternational bloodInternational blood marrow transplant researchUniversity of bonn school medicine